Markus K. Larsson

Increased levels of IL-6 in the cerebrospinal fluid of patients with chronic schizophrenia — significance for activation of the kynurenine pathway

Lilly Schwieler, Markus K. Larsson, Elisabeth Skogh et al. · Journal of Psychiatry and Neuroscience · 2015 · 225 citations · Full text

Life Sciences, Neuroscience, Psychiatry +17

A genome-wide association study of kynurenic acid in cerebrospinal fluid: implications for psychosis and cognitive impairment in bipolar disorder

Carl M. Sellgren, Magdalena E. Kegel, Sarah E. Bergen et al. · Molecular Psychiatry · 2015 · 103 citations · Full text

Life Sciences, Genetics, Neuroscience +15

Adaptive and Behavioral Changes in Kynurenine 3-Monooxygenase Knockout Mice: Relevance to Psychotic Disorders

Sophie Erhardt, Ana Pocivavsek, Mariaelena Repici et al. · Biological Psychiatry · 2016 · 64 citations · Full text

Life Sciences, Neuroscience, Pharmacology +9

Inhibition of kynurenine aminotransferase II reduces activity of midbrain dopamine neurons

Klas R. Linderholm, Maximilian Tufvesson‐Alm, Markus K. Larsson et al. · Neuropharmacology · 2015 · 45 citations · Full text

Medicine, Neuroscience, Pharmacology +13

Behavioral disturbances in adult mice following neonatal virus infection or kynurenine treatment – Role of brain kynurenic acid

Xi-Cong Liu, M. Holtze, Susan B. Powell et al. · Brain Behavior and Immunity · 2013 · 43 citations · Full text

Life Sciences, Neuroscience, Pharmacology +17